• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ovarian carcinoma in two patients with chronic liver disease.两名慢性肝病患者发生卵巢癌。
World J Gastroenterol. 2005 Jul 28;11(28):4445-6. doi: 10.3748/wjg.v11.i28.4445.
2
[Ascites as the first manifestation of ovarian cancer in the disseminated stage--case report].[腹水作为播散期卵巢癌的首发表现——病例报告]
Pol Merkur Lekarski. 2011 Oct;31(184):233-5.
3
Elevation of CA 125 in patients with benign and malignant ascites.良性和恶性腹水患者CA 125水平升高。
Cancer. 1987 Jan 15;59(2):213-7. doi: 10.1002/1097-0142(19870115)59:2<213::aid-cncr2820590206>3.0.co;2-i.
4
[Chylous ascites in 12 patients undergoing peritoneal dialysis].[12例接受腹膜透析患者的乳糜性腹水]
Nephrologie. 1994;15(3):201-5.
5
Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: a prospective study.慢性丙型肝炎病毒感染所致肝硬化对卵巢癌预后的影响:一项前瞻性研究。
BMC Cancer. 2015 Oct 21;15:754. doi: 10.1186/s12885-015-1805-9.
6
[Zinc content of the ascitic fluid caused by malignant ovarian neoplasms and liver cirrhosis].[恶性卵巢肿瘤和肝硬化所致腹水的锌含量]
Ann Ostet Ginecol Med Perinat. 1967 Apr;89(4):273-7.
7
Peritoneovenous shunting for intractable ascites.
Scand J Gastroenterol. 1982 Nov;17(8):1009-12.
8
Recurrent breast cancer presents as a single solid ovarian mass and ascites.复发性乳腺癌表现为单一实性卵巢肿块和腹水。
Taiwan J Obstet Gynecol. 2006 Dec;45(4):356-9. doi: 10.1016/S1028-4559(09)60261-8.
9
Origin of fat in chylous ascites of patients with liver cirrhosis.肝硬化患者乳糜性腹水中脂肪的来源。
Gastroenterology. 1974 Nov;67(5):878-86.
10
[Prognostic significance of ascites in patients with liver cirrhosis].[肝硬化患者腹水的预后意义]
Vnitr Lek. 1994 Nov;40(11):735-8.

引用本文的文献

1
Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.基于泛素相关基因的卵巢癌预后标志物鉴定提示 FBXO9 的潜在作用
Biomolecules. 2023 Nov 30;13(12):1724. doi: 10.3390/biom13121724.

本文引用的文献

1
How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.如何解读有浆膜受累患者的血清CA 125水平?一个临床难题。
Oncology. 2003;65(1):1-6. doi: 10.1159/000071198.
2
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.肝硬化腹水的管理:国际腹水俱乐部共识会议报告
Hepatology. 2003 Jul;38(1):258-66. doi: 10.1053/jhep.2003.50315.
3
Screening for ovarian cancer.
Med J Aust. 2003 Jun 16;178(12):655-6. doi: 10.5694/j.1326-5377.2003.tb05399.x.
4
Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit.初级保健转诊延迟对上皮性卵巢癌女性患者生存率的影响:回顾性审计
BMJ. 2002 Jan 19;324(7330):148-51. doi: 10.1136/bmj.324.7330.148.
5
Ascites.
Clin Liver Dis. 2000 Feb;4(1):151-68, vii. doi: 10.1016/s1089-3261(05)70101-x.
6
Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.肝硬化腹水患者的生存及预后因素:134例门诊患者的研究
Am J Gastroenterol. 1993 Apr;88(4):514-9.
7
A 20-year prospective study of cirrhosis.一项关于肝硬化的20年前瞻性研究。
Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):263-6. doi: 10.1136/bmj.282.6260.263.
8
Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases.良性和恶性疾病患者血清中的胎盘碱性磷酸酶和癌抗原125
Clin Chem. 1985 May;31(5):687-90.
9
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.因腹水入院治疗的肝硬化患者动脉压、内源性血管活性系统及肾功能的预后价值
Gastroenterology. 1988 Feb;94(2):482-7. doi: 10.1016/0016-5085(88)90441-6.
10
Elevation of CA 125 in patients with benign and malignant ascites.良性和恶性腹水患者CA 125水平升高。
Cancer. 1987 Jan 15;59(2):213-7. doi: 10.1002/1097-0142(19870115)59:2<213::aid-cncr2820590206>3.0.co;2-i.

两名慢性肝病患者发生卵巢癌。

Ovarian carcinoma in two patients with chronic liver disease.

作者信息

Isildak Mehlika, Guven Gulay-Sain, Kekilli Murat, Beyazit Yavuz, Erman Mustafa

机构信息

Department of Internal Medicine, Section of General Internal Medicine, Faculty of Medicine, Hacettepe University, Sihhiye, Ankara 06100, Turkey.

出版信息

World J Gastroenterol. 2005 Jul 28;11(28):4445-6. doi: 10.3748/wjg.v11.i28.4445.

DOI:10.3748/wjg.v11.i28.4445
PMID:16038052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4434680/
Abstract

Ascites is a common and debilitating complication of cirrhosis. However, patients with chronic liver disease are not spared from other causes of ascites and physicians should be careful not to miss an underlying malignancy. Ovarian cancer is an insidious disease, which is difficult to diagnose and it ranks first in mortality among all gynecological cancers. Here, we present two cases of patients with chronic liver disease that developed ascites not simply because of cirrhosis but as a manifestation of ovarian cancer. We would like to emphasize that the causes of ascites, other than the liver itself, should not be overlooked in patients with chronic liver disease.

摘要

腹水是肝硬化常见且使人虚弱的并发症。然而,慢性肝病患者也可能因其他原因出现腹水,医生应注意避免漏诊潜在的恶性肿瘤。卵巢癌是一种隐匿性疾病,难以诊断,在所有妇科癌症中死亡率居首。在此,我们报告两例慢性肝病患者,其腹水并非单纯由肝硬化引起,而是卵巢癌的一种表现。我们要强调的是,慢性肝病患者不应忽视肝脏本身以外导致腹水的原因。